CI Investments’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
Other funds holding EW
CI Investments's EW Position: Q3 2026 in Review
CI Investments reduced its Edwards Lifesciences (EW) stake by 11% in Q3 2026, selling an estimated $341K and leaving 29,815 shares worth $2.57M. The position accounts for 0.01% of the portfolio, ranked #410.
CI Investments first reported a position in EW in Q3 2019 and has held it in 28 quarters since. The position peaked at $246M in Q1 2022. 1,345 funds tracked by Wall St. Rank hold EW as of Q3 2026.
- CI Investments held 29,815 shares of Edwards Lifesciences worth $2.57M as of Q3 2026.
- CI Investments sold 3,835 Edwards Lifesciences shares in Q3 2026, an estimated $341K.
- Edwards Lifesciences made up 0.01% of CI Investments's portfolio in Q3 2026, its #410 holding.
- CI Investments first reported a position in Edwards Lifesciences in Q3 2019 and has held it in 28 quarters since.
- CI Investments's Edwards Lifesciences position peaked at $246M in Q1 2022.
- 1,345 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q3 2026.
Based on CI Investments's 13F filing for Q3 2026, filed 12 Nov 2026.